ABBV · News · 20260901N

Product Launch and Transition

AbbVie Inc. · 2026-09-01 · Importance 54 · Surprise 74

Allergan Aesthetics launched SkinMedica Barrier Calming Cream, a regenerative skincare product intended to restore and fortify the skin barrier. The product uses Calcium Strengthening Complex and Botanical Calming Complex and reduced dryness by 30% in clinical testing. SkinMedica also introduced HA 5 Hydra Collagen Facial Mist, which delivered a 31% immediate increase in skin hydration, indicating expansion of the premium skincare offering.

Key facts

• In clinical testing, SkinMedica's Barrier Calming Cream improved skin barrier support and reduced dryness by 30%. source
• SkinMedica introduced the HA 5® Hydra Collagen Facial Mist which showed an immediate increase in skin hydration by 31%. source
• Allergan Aesthetics, an AbbVie company, launched SkinMedica's Barrier Calming Cream, a new regenerative skincare product designed to restore and fortify the skin barrier. source
• Advisors Capital Management LLC bought 505,318 shares of AbbVie Inc. during the second quarter, valued at approximately $127,158,000, and AbbVie makes up about 1.3% of Advisors Capital Management LLC's portfolio. source
• Beckerman Institutional LLC bought 2,028 shares of AbbVie Inc. in the second quarter, valued at approximately $510,000. source